| Item Type | Name |
|
Academic Article
|
Surgical technique for right lobe adult living donor liver transplantation without venovenous bypass or portocaval shunting and with duct-to-duct biliary reconstruction.
|
|
Academic Article
|
A multicenter, open-label, comparative trial of two daclizumab dosing strategies vs. no antibody induction in combination with tacrolimus, mycophenolate mofetil, and steroids for the prevention of acute rejection in simultaneous kidney-pancreas transplant recipients: interim analysis.
|
|
Academic Article
|
Impact of hepatitis C virus status in pancreas transplantation: a case controlled study.
|
|
Academic Article
|
Thymoglobulin for induction or rejection therapy in pancreas allograft recipients: a single centre experience.
|
|
Academic Article
|
Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure.
|
|
Academic Article
|
Two-dose daclizumab regimen in simultaneous kidney-pancreas transplant recipients: primary endpoint analysis of a multicenter, randomized study.
|
|
Academic Article
|
Pancreas transplantation in type 1 diabetes.
|
|
Academic Article
|
Retransplantation in patients with graft loss caused by polyoma virus nephropathy.
|
|
Academic Article
|
Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients.
|
|
Academic Article
|
Evaluation of an immunosuppressant side effect instrument.
|
|
Academic Article
|
Pancreas and islet transplantation in type 1 diabetes.
|
|
Academic Article
|
Intermediate-term outcomes with expanded criteria deceased donors in kidney transplantation: a spectrum or specter of quality?
|
|
Academic Article
|
Experience with deceased donor kidney transplantation in 114 patients over age 60.
|
|
Academic Article
|
Banff schema for grading pancreas allograft rejection: working proposal by a multi-disciplinary international consensus panel.
|
|
Academic Article
|
Experience in renal and extrarenal transplantation with donation after cardiac death donors with selective use of extracorporeal support.
|
|
Academic Article
|
Management of leukopenia in kidney and pancreas transplant recipients.
|
|
Academic Article
|
Import pancreas allografts: good from far or far from good?
|
|
Academic Article
|
Single center experience transplanting kidneys from deceased donors with terminal acute renal failure.
|
|
Academic Article
|
Relationship between assays of glycemia in diabetic subjects with advanced chronic kidney disease.
|
|
Academic Article
|
Kidney transplantation from donation after cardiac death donors: lack of impact of delayed graft function on post-transplant outcomes.
|
|
Academic Article
|
Pancreas transplantation for type 2 diabetes mellitus.
|
|
Academic Article
|
Preparation of the pancreas allograft for transplantation.
|
|
Academic Article
|
Lessons learned from a single center's experience with 134 donation after cardiac death donor kidney transplants.
|
|
Academic Article
|
Regenerative medicine and organ transplantation: past, present, and future.
|
|
Academic Article
|
Hypertension in standard criteria deceased donors is associated with inferior outcomes following kidney transplantation.
|
|
Academic Article
|
Cell and organ bioengineering technology as applied to gastrointestinal diseases.
|
|
Academic Article
|
Regeneration and bioengineering of transplantable abdominal organs: current status and future challenges.
|
|
Academic Article
|
Evolving experience using kidneys from deceased donors with terminal acute kidney injury.
|
|
Academic Article
|
Use of FK 506 for the prevention of recurrent allograft rejection after successful conversion from cyclosporine for refractory rejection. US Multicenter FK 506 Liver Study Group.
|
|
Academic Article
|
Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.
|
|
Academic Article
|
Ganciclovir therapy for viral disease in liver transplant recipients.
|
|
Academic Article
|
In-situ split-liver transplantation.
|
|
Academic Article
|
FK 506 for rescue treatment of acute and chronic rejection in liver allograft recipients.
|
|
Academic Article
|
Long-term outcome of simultaneous kidney-pancreas transplantation: analysis of 61 patients with more than 5 years follow-up.
|
|
Academic Article
|
Pancreas and islet transplantation for patients with diabetes.
|
|
Academic Article
|
The dual kidney transplant registry.
|
|
Academic Article
|
Experience with OKT3 after orthotopic liver transplantation.
|
|
Academic Article
|
Pancreas after kidney transplantation.
|
|
Academic Article
|
Pancreas transplantation for patients with type 1 diabetes.
|
|
Academic Article
|
Renal allograft loss as the result of polyomavirus interstitial nephritis after simultaneous kidney-pancreas transplantation: results with kidney retransplantation.
|
|
Academic Article
|
Improving results in solitary pancreas transplantation with portal-enteric drainage, thymoglobin induction, and tacrolimus/mycophenolate mofetil-based immunosuppression.
|
|
Academic Article
|
Long-term experience with simultaneous kidney-pancreas transplantation with portal-enteric drainage and tacrolimus/mycophenolate mofetil-based immunosuppression.
|
|
Academic Article
|
Increased kidney transplantation utilizing expanded criteria deceased organ donors with results comparable to standard criteria donor transplant.
|
|
Academic Article
|
Kidney and pancreas transplantation at Wake Forest University Baptist Medical Center.
|
|
Academic Article
|
Massive immune hemolysis caused by anti-D after dual kidney transplantation.
|
|
Academic Article
|
Optimal use of older donors and recipients in kidney transplantation.
|
|
Academic Article
|
Clinical utility of histological features of polyomavirus allograft nephropathy.
|
|
Academic Article
|
Experience with dual kidney transplants from donors at the extremes of age.
|
|
Academic Article
|
Influence of pulsatile perfusion preservation on outcomes in kidney transplantation from expanded criteria donors.
|
|
Academic Article
|
The metabolic syndrome as a risk factor in simultaneous kidney-pancreas transplantation.
|
|
Academic Article
|
Dual kidney transplantation: a case-control comparison with single kidney transplantation from standard and expanded criteria donors.
|
|
Academic Article
|
A randomized trial of alemtuzumab vs. anti-thymocyte globulin induction in renal and pancreas transplantation.
|
|
Academic Article
|
Advances in immunosuppression for pancreas transplantation.
|
|
Academic Article
|
Successful kidney transplantation from a donation after cardiac death donor with acute renal failure and bowel infarction using extracorporeal support.
|
|
Academic Article
|
A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation.
|
|
Academic Article
|
Defining the risks for cytomegalovirus infection and disease after solid organ transplantation.
|
|
Academic Article
|
The pancreas allograft donor: current status, controversies, and challenges for the future.
|
|
Academic Article
|
Regenerative medicine as applied to solid organ transplantation: current status and future challenges.
|
|
Academic Article
|
Cost-effective immunosuppressive options for solid organ transplantation: a guide to lower cost for the renal transplant recipient in the USA.
|
|
Academic Article
|
Clinical operational tolerance after renal transplantation: current status and future challenges.
|
|
Academic Article
|
Pancreas transplantation: lessons learned from a decade of experience at Wake Forest Baptist Medical Center.
|
|
Academic Article
|
Gout and transplantation: new treatment option-same old drug interaction.
|
|
Academic Article
|
Risk factors for sensitization by blood transfusions. Comparison of the UW/Madison and UC/San Francisco donor-specific transfusion experience.
|
|
Academic Article
|
How regenerative medicine may contribute to the achievement of an immunosuppression-free state.
|
|
Academic Article
|
Pancreas graft thrombosis: causes, prevention, diagnosis, and intervention.
|
|
Academic Article
|
Regenerative medicine as applied to general surgery.
|
|
Academic Article
|
Immunoisolation: where regenerative medicine meets solid organ transplantation.
|
|
Academic Article
|
Treatment options for renal cell carcinoma in renal allografts: a case series from a single institution.
|
|
Academic Article
|
Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.
|
|
Academic Article
|
A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation.
|
|
Academic Article
|
Sonography of renal transplants in dogs: the effect of acute tubular necrosis, cyclosporine nephrotoxicity, and acute rejection on resistive index and renal length.
|
|
Academic Article
|
Superior efficacy of oral ganciclovir over oral acyclovir for cytomegalovirus prophylaxis in kidney-pancreas and pancreas alone recipients.
|
|
Academic Article
|
Anti-insulin antibodies may cause hypoglycaemia following pancreas transplantation.
|
|
Concept
|
Pancreas Transplantation
|
|
Concept
|
Corneal Transplantation
|
|
Concept
|
Liver Transplantation
|
|
Concept
|
Organ Transplantation
|
|
Concept
|
Transplantation Immunology
|
|
Concept
|
Transplantation Tolerance
|
|
Concept
|
Transplantation Conditioning
|
|
Concept
|
Transplantation, Homologous
|
|
Concept
|
Kidney Transplantation
|
|
Concept
|
Heart Transplantation
|
|
Concept
|
Stem Cell Transplantation
|
|
Concept
|
Cell Transplantation
|
|
Concept
|
Islets of Langerhans Transplantation
|
|
Concept
|
Transplantation
|
|
Academic Article
|
Discarded human kidneys as a source of ECM scaffold for kidney regeneration technologies.
|
|
Academic Article
|
Organ bioengineering and regeneration as the new Holy Grail for organ transplantation.
|
|
Academic Article
|
Will regenerative medicine replace transplantation?
|
|
Academic Article
|
Ethnicity, medical insurance, and living kidney donation.
|
|
Academic Article
|
Immunosuppression for pancreas transplantation with an emphasis on antibody induction strategies: review and perspective.
|
|
Academic Article
|
Pancreas transplantation with portal venous drainage with an emphasis on technical aspects.
|
|
Academic Article
|
Successful unintentional ABO-incompatible renal transplantation: Blood group A1B donor into an A2B recipient.
|
|
Academic Article
|
Cell replacement strategies aimed at reconstitution of the ß-cell compartment in type 1 diabetes.
|
|
Academic Article
|
Osseus metaplasia in kidney allografts as a paradigm of regenerative medicine principles.
|
|
Academic Article
|
Depleting antibody induction in simultaneous pancreas-kidney transplantation: a prospective single-center comparison of alemtuzumab versus rabbit anti-thymocyte globulin.
|
|
Academic Article
|
Retrieval of the pancreas allograft for whole-organ transplantation.
|
|
Academic Article
|
Influence of recipient age on deceased donor kidney transplant outcomes in the expanded criteria donor era.
|
|
Academic Article
|
Pancreas transplantation: The Wake Forest experience in the new millennium.
|
|
Academic Article
|
Simultaneous transplantation of the living donor kidney and deceased donor pancreas and other transplant options for diabetic and uremic patients.
|
|
Academic Article
|
Semi-xenotransplantation: the regenerative medicine-based approach to immunosuppression-free transplantation and to meet the organ demand.
|
|
Academic Article
|
Prospect for kidney bioengineering: shortcomings of the status quo.
|
|
Academic Article
|
Pancreas transplantation in C-peptide positive patients: does "type" of diabetes really matter?
|
|
Academic Article
|
Donor-derived myeloid sarcoma in two kidney transplant recipients from a single donor.
|
|
Academic Article
|
Role of allograft nephrectomy following kidney graft failure: preliminary experience with pre-operative angiographic kidney embolization.
|
|
Academic Article
|
The search for the optimal antibody induction strategy in kidney transplantation: still "hazy" after all these years.
|
|
Academic Article
|
Renal Extracellular Matrix Scaffolds From Discarded Kidneys Maintain Glomerular Morphometry and Vascular Resilience and Retains Critical Growth Factors.
|
|
Academic Article
|
Deceased donor multidrug resistance protein 1 and caveolin 1 gene variants may influence allograft survival in kidney transplantation.
|
|
Academic Article
|
APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors.
|
|
Academic Article
|
Kidney transplantation, bioengineering and regeneration: an originally immunology-based discipline destined to transition towards ad hoc organ manufacturing and repair.
|
|
Academic Article
|
Dual kidney transplants from adult marginal donors successfully expand the limited deceased donor organ pool.
|
|
Academic Article
|
Exocrine drainage in vascularized pancreas transplantation in the new millennium.
|
|
Academic Article
|
Pancreas transplantation: a decade of decline.
|
|
Academic Article
|
The future of pancreas transplantation: 'ain't what it used to be'.
|
|
Academic Article
|
Successful ABO-Incompatible Renal Transplantation: ?Blood Group A1B Donor Into A2B Recipient With Anti-A1 Isoagglutinins.
|
|
Academic Article
|
Single-Center Experience with Deceased Donor Kidney Transplantation in 114 Individuals Aged 70 and Older in the New Millennium.
|
|
Academic Article
|
Transplant Center Volume and the Risk of Pancreas Allograft Failure.
|
|
Academic Article
|
Severe intellectual disability is not a contraindication to kidney transplantation in children.
|
|
Academic Article
|
Analysis of local versus imported expanded criteria donor kidneys: A single-center experience with 497 ECD kidney transplants.
|
|
Academic Article
|
Eversion endarterectomy of the deceased donor renal artery to prevent kidney discard.
|
|
Academic Article
|
Pancreas transplantation for type I diabetes mellitus.
|
|
Academic Article
|
Molecular Pathways Underlying Adaptive Repair of the Injured Kidney: Novel Donation After Cardiac Death and Acute Kidney Injury Platforms.
|
|
Academic Article
|
Is prolonged cold ischemia a contraindication to using kidneys from acute kidney injury donors?
|
|
Academic Article
|
Delayed spontaneous hepatitis C virus elimination in a renal transplant patient following graft rejection.
|
|
Academic Article
|
Dual Kidney Transplantation from Donors at the Extremes of Age.
|
|
Academic Article
|
Clear cell papillary renal cell carcinoma in a transplant kidney.
|
|
Academic Article
|
C-peptide levels do not correlate with pancreas allograft failure: Multicenter retrospective analysis and discussion of the new OPT definition of pancreas allograft failure.
|